Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Global availability of parenteral nutrition: Pre- and post-COVID-19 pandemic surveys
Ist Teil von
Nutrition (Burbank, Los Angeles County, Calif.), 2024-07, Vol.123, p.112396-112396, Article 112396
Ort / Verlag
United States: Elsevier Inc
Erscheinungsjahr
2024
Link zum Volltext
Quelle
MEDLINE
Beschreibungen/Notizen
•Parenteral nutrition represents a therapeutic option for patients with type 3 intestinal failure; if used exclusively, parenteral nutrition must be complete to provide all essential nutrients.•An international survey using an electronic questionnaire was conducted in August 2019 and repeated in May 2022; 36 country representatives responded.•The study reported on the high availability of parenteral nutrition worldwide.•Shortages may have a substantial effect on the quality of parenteral nutrition admixtures.•Conflicts of interest: Stanislaw Klek acts as a lecturer and consultant for B Braun, Fresenius Kabi, Nutricia Polska Ltd., Nestle, Baxter, and Takeda. Stephane M. Schneider acts as a speaker, advisory board member, and researcher with B. Braun, Baxter, and Fresenius-Kabi. The other authors declare no potential or actual personal, political, or financial interest in the material, information, or techniques described in the article.
Parenteral nutrition represents a therapeutic option for patients with type 3 intestinal failure. If used exclusively, parenteral nutrition has to be complete to provide all essential nutrients. The aim was to assess the availability of parenteral nutrition in all parts of the world, to better comprehend the global situation, and to prepare an action plan to increase access to parenteral nutrition.
An international survey using an electronic questionnaire was conducted in August 2019 and repeated in May 2022. An electronic questionnaire was sent to 52 members or affiliates of the International Clinical Nutrition Section of the American Society for Parenteral and Enteral Nutrition. Questions addressed the availability of parenteral nutrition admixtures and their components, reimbursement, and prescribing pre- and post-COVID-19 pandemic. All participating countries were categorized by their economic status.
Thirty-six country representatives responded, answering all questions. Parenteral nutrition was available in all countries (100%), but in four countries (11.1%) three-chamber bags were the only option, and in six countries a multibottle system was still used. Liver-sparing amino acids were available in 18 (50%), kidney-sparing in eight (22.2%), and electrolyte-free in 11 (30.5%) countries (30.5%). In most countries (n = 28; 79.4%), fat-soluble and water-soluble vitamins were available. Trace elements solutions were unavailable in four (11.1%) countries. Parenteral nutrition was reimbursed in most countries (n = 33; 91.6%). No significant problems due to the coronavirus pandemic were reported.
Despite the apparent high availability of parenteral nutrition worldwide, there are some factors that may have a substantial effect on the quality of parenteral nutrition admixtures. These shortages create an environment of inequality.